Olaparib is an oral, first-in-class poly (ADP-ribose) polymerase (PARP) inhibitor used in the treatment of cancers with deficiencies in homologous recombination repair (HRR), particularly those harboring BRCA mutations.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea